Journal
CELL HOST & MICROBE
Volume 30, Issue 3, Pages 273-274Publisher
CELL PRESS
DOI: 10.1016/j.chom.2022.02.008
Keywords
-
Categories
Ask authors/readers for more resources
Colistin, an antibiotic used as a last resort for treating Gram-negative bacterial infections, is facing rapid resistance. However, a recent study published in Nature discovered and synthesized a natural variant that can bypass colistin resistance, offering new hope in the fight against antimicrobial resistance.
Colistin is an antibiotic of last resort for treating Gram-negative bacterial infections, but resistance is spreading rapidly. In a recent issue of Nature, Wang et al. use genome mining to identify and synthesize a natural variant that bypasses colistin resistance and offers new hope for tackling antimicrobial resistance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available